vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.2B vs $510.9M, roughly 2.4× Genius Sports Ltd). Alignment Healthcare, Inc. runs the higher net margin — 0.9% vs -12.3%, a 13.3% gap on every dollar of revenue. Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 34.6%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.

ALHC vs GENI — Head-to-Head

Bigger by revenue
ALHC
ALHC
2.4× larger
ALHC
$1.2B
$510.9M
GENI
Higher net margin
ALHC
ALHC
13.3% more per $
ALHC
0.9%
-12.3%
GENI
Faster 2-yr revenue CAGR
GENI
GENI
Annualised
GENI
129.2%
34.6%
ALHC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALHC
ALHC
GENI
GENI
Revenue
$1.2B
$510.9M
Net Profit
$11.4M
$-63.0M
Gross Margin
25.2%
Operating Margin
-11.5%
Net Margin
0.9%
-12.3%
Revenue YoY
-74.7%
Net Profit YoY
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
GENI
GENI
Q1 26
$1.2B
Q4 25
$1.0B
$510.9M
Q3 25
$993.7M
$335.4M
Q2 25
$1.0B
$215.2M
Q1 25
$926.9M
$119.7M
Q4 24
$701.2M
$413.0M
Q3 24
$692.4M
$285.8M
Q2 24
$681.3M
$184.1M
Net Profit
ALHC
ALHC
GENI
GENI
Q1 26
$11.4M
Q4 25
$-11.0M
$-63.0M
Q3 25
$3.7M
Q2 25
$15.7M
$-47.3M
Q1 25
$-9.1M
$-25.5M
Q4 24
$-31.1M
$-85.5M
Q3 24
$-26.4M
$-47.1M
Q2 24
$-24.0M
$-35.5M
Gross Margin
ALHC
ALHC
GENI
GENI
Q1 26
Q4 25
25.2%
Q3 25
24.2%
Q2 25
19.1%
Q1 25
10.7%
Q4 24
16.7%
Q3 24
20.5%
Q2 24
18.6%
Operating Margin
ALHC
ALHC
GENI
GENI
Q1 26
Q4 25
-1.0%
-11.5%
Q3 25
0.8%
-15.3%
Q2 25
2.2%
-21.0%
Q1 25
-0.6%
-20.3%
Q4 24
-3.2%
-18.0%
Q3 24
-2.8%
-13.9%
Q2 24
-2.7%
-16.8%
Net Margin
ALHC
ALHC
GENI
GENI
Q1 26
0.9%
Q4 25
-1.1%
-12.3%
Q3 25
0.4%
Q2 25
1.5%
-22.0%
Q1 25
-1.0%
-21.3%
Q4 24
-4.4%
-20.7%
Q3 24
-3.8%
-16.5%
Q2 24
-3.5%
-19.3%
EPS (diluted)
ALHC
ALHC
GENI
GENI
Q1 26
Q4 25
$-0.04
Q3 25
$0.02
Q2 25
$0.07
Q1 25
$-0.05
Q4 24
$-0.15
Q3 24
$-0.14
Q2 24
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
GENI
GENI
Cash + ST InvestmentsLiquidity on hand
$705.6M
$280.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.9M
$724.5M
Total Assets
$1.3B
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
GENI
GENI
Q1 26
$705.6M
Q4 25
$604.2M
$280.6M
Q3 25
$644.1M
$110.2M
Q2 25
$503.8M
$110.2M
Q1 25
$479.5M
$110.2M
Q4 24
$470.6M
$100.3M
Q3 24
$381.0M
$100.3M
Q2 24
$363.7M
$100.3M
Total Debt
ALHC
ALHC
GENI
GENI
Q1 26
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Stockholders' Equity
ALHC
ALHC
GENI
GENI
Q1 26
$206.9M
Q4 25
$179.3M
$724.5M
Q3 25
$161.9M
$572.4M
Q2 25
$141.0M
$572.4M
Q1 25
$108.1M
$572.4M
Q4 24
$99.9M
$573.0M
Q3 24
$114.5M
$573.0M
Q2 24
$123.7M
$573.0M
Total Assets
ALHC
ALHC
GENI
GENI
Q1 26
$1.3B
Q4 25
$1.1B
$1.1B
Q3 25
$1.1B
$792.3M
Q2 25
$1.0B
$792.3M
Q1 25
$895.6M
$792.3M
Q4 24
$782.1M
$775.7M
Q3 24
$692.3M
$775.7M
Q2 24
$716.3M
$775.7M
Debt / Equity
ALHC
ALHC
GENI
GENI
Q1 26
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
GENI
GENI
Operating Cash FlowLast quarter
$128.7M
$81.9M
Free Cash FlowOCF − Capex
$69.6M
FCF MarginFCF / Revenue
13.6%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
11.27×
TTM Free Cash FlowTrailing 4 quarters
$33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
GENI
GENI
Q1 26
$128.7M
Q4 25
$-50.4M
$81.9M
Q3 25
$144.6M
$-4.8M
Q2 25
$29.1M
$-1.2M
Q1 25
$16.6M
$-14.6M
Q4 24
$-8.7M
$14.9M
Q3 24
$26.2M
$-9.2M
Q2 24
$23.5M
Free Cash Flow
ALHC
ALHC
GENI
GENI
Q1 26
Q4 25
$-55.4M
$69.6M
Q3 25
$139.1M
$-14.2M
Q2 25
$21.1M
$-5.8M
Q1 25
$8.4M
$-16.0M
Q4 24
$-18.0M
$11.3M
Q3 24
$16.9M
$-11.6M
Q2 24
$11.8M
FCF Margin
ALHC
ALHC
GENI
GENI
Q1 26
Q4 25
-5.5%
13.6%
Q3 25
14.0%
-4.2%
Q2 25
2.1%
-2.7%
Q1 25
0.9%
-13.4%
Q4 24
-2.6%
2.7%
Q3 24
2.4%
-4.1%
Q2 24
1.7%
Capex Intensity
ALHC
ALHC
GENI
GENI
Q1 26
Q4 25
0.5%
2.4%
Q3 25
0.6%
2.8%
Q2 25
0.8%
2.1%
Q1 25
0.9%
1.2%
Q4 24
1.3%
0.9%
Q3 24
1.3%
0.9%
Q2 24
1.7%
Cash Conversion
ALHC
ALHC
GENI
GENI
Q1 26
11.27×
Q4 25
Q3 25
38.77×
Q2 25
1.86×
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons